| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/19/2008 | US20080146624 Amidines as modulators of indoleamine 2,3-dioxygenase |
| 06/19/2008 | US20080146623 Inhibitors of histone deacetylase and prodrugs thereof |
| 06/19/2008 | US20080146622 E.g., rotigotine; have neuroprotective properties and can be used for treatment or prophylaxis of dopaminergic cell loss, particularly in very early stages of Parkinson's disease or in high-risk patients |
| 06/19/2008 | US20080146621 N-{[1-(Methylamino)cyclopropyl]methyl}pyridin-3-amine dihydrochloride; treatment of neuropathologies associated with cerebral ageing, of mood disorders, of pain and of tobacco withdrawal; selective nicotinic ligands of the central receptor sub-type alpha 4 beta 2 |
| 06/19/2008 | US20080146620 Dibenzylamine Compounds and Pharmaceutical Use Thereof |
| 06/19/2008 | US20080146619 Certain chemical entities, compositions, and methods |
| 06/19/2008 | US20080146618 CA IX-Specific Inhibitors |
| 06/19/2008 | US20080146617 Methods of treating inflammatory diseases |
| 06/19/2008 | US20080146616 Indoles Useful in the Treatment of Inflammation |
| 06/19/2008 | US20080146615 Pharmaceutical Compositions Comprising Amorphous Benzimidazole Compounds |
| 06/19/2008 | US20080146614 Therapeutic Agents |
| 06/19/2008 | US20080146613 Piperidine-amino-benzimidazole derivatives as inhibitors of respiratory syncytial virus replication |
| 06/19/2008 | US20080146612 Novel Biaromatic Compounds, Inhibitors of the P2X7-Receptor |
| 06/19/2008 | US20080146611 Transient Receptor Potential channel modulators; N-(2-pyridinyloxy- or 2-pyridinylthio-alkanoyl)quinolines; acute or chronic pain, sensitivity, burns, diabetic neuropathy, psoriasis, eczema, dermatitis, post-herpetic neuralgia, migraine, incontinence, fever, hot flashes, osteoarthritis; depilatories |
| 06/19/2008 | US20080146610 Isotopically substituted proton pump inhibitors |
| 06/19/2008 | US20080146609 5-[3-(6,8-Dibromo-1,2,3,4-tetrahydro-quinolin-4-ylamino)-propylamino]-4H-thieno [3,2-b]pyridin-7-one, used as inhibitors of bacterial methionyl tRNA synthetase, administered for the treatment of bacterial infections; therapy for Clostridium difficile based infections |
| 06/19/2008 | US20080146608 drugs such as 5-(6-Chloropyridazin-3-yl)-1-azabicyclo[3.2.1]octane, used for treatment or prevention of disorders related to a nicotinic receptor dysfunction |
| 06/19/2008 | US20080146607 heterocyclic ketones such as (3-Benzyl-pyrrolidin-3-yl)-(1H-indol-5-yl)-methanone, used as antidepressants or anxiolytic agents |
| 06/19/2008 | US20080146606 Novel compounds |
| 06/19/2008 | US20080146605 Preparation and utility of ccr5 inhibitors |
| 06/19/2008 | US20080146604 adenosine receptor antagonists such as 2-(4-Methoxyphenyl)-9-benzylamino-10-cyano-s-triazolo[1,5-a]quinolin, used for treating respiratory system disorders, vision disorders, tumors, allergies or inflammatory disease, ischemia, hypoxia, arrhythmia or urogential disorders |
| 06/19/2008 | US20080146603 Combinations comprising antimuscarinic agents and beta-adrenergic agonists |
| 06/19/2008 | US20080146602 3-Chloro-2-[(2,4-dioxo-1,3-oxazolidin-3-yl)methyl]-5,6,7,8-tetrahydro-4-(4-methoxyphenyl)[1]benzothieno[2,3-b]pyridine-7-carboxamide, salts and prodrugs, used as antiinflammatory agents and for treatment of autoimmune diseases |
| 06/19/2008 | US20080146601 Method for making analgesics |
| 06/19/2008 | US20080146600 potent proline transporter inhibitors such as (S)-2-(4-((3'-chlorobiphenyl-4-yl)(hydroxy)methyl)piperidin-1-yl)pyrimidin-5-ol, used as cognition activators or for treatment of brain disorders |
| 06/19/2008 | US20080146599 receptor tyrosine kinase inhibitors such as 2-chloro-N-{3-[(4,6-diaminopyrimidin-5-yl)ethynyl]phenyl}benzenesulfonamide, used as angiogenesis inhibitors in mammals |
| 06/19/2008 | US20080146598 Combinatorial drug therapy using polymer-drug conjugates |
| 06/19/2008 | US20080146597 Therapeutic Tetrahydroisoquinoline-Based Compositions for Cancer Therapy |
| 06/19/2008 | US20080146596 Such as (R)-2-(4-((3'-chlorobiphenyl-4-yl)(hydroxy)methyl)piperidin-1-yl)pyrimidin-5-ol for treating age-associated memory impairment, Alzheimer's disease, attention-deficit/hyperactivity disorder, autism, Down syndrome, Fragile X syndrome, Huntington's disease, Parkinson's disease, or schizophrenia |
| 06/19/2008 | US20080146595 Non-nucleoside reverse transcriptase inhibitors |
| 06/19/2008 | US20080146594 Thrombopoietin activity modulating compounds and methods |
| 06/19/2008 | US20080146593 Substituted 5-Phenyl Pyrimidines I In Therapy |
| 06/19/2008 | US20080146592 Method of Treating Preeclampsia Employing Metolazone |
| 06/19/2008 | US20080146591 Contains non-hygroscopic organic acid as stabilizer; for oral administration, after being constituted in water |
| 06/19/2008 | US20080146590 P38 map kinase inhibitors and methods for using the same |
| 06/19/2008 | US20080146589 Chromenone derivatives |
| 06/19/2008 | US20080146588 Piperidinyl Piperidine Tachykinin Receptor Antagonists |
| 06/19/2008 | US20080146587 for enhancing cognitive memory in an Alzheimer's patient; 5-HT2-selective and 5-HT6 selective ligands |
| 06/19/2008 | US20080146586 antitumor and antibiotic activity which can be used as anticancer agents; exhibit specific and intensive activity in inhibiting tyrosine kinase of the growth factor receptor, and show negligible side-effects compared |
| 06/19/2008 | US20080146585 Use Of C-Kit Inhibitors For Treating Inflammatory Muscle Disorders Including Myositis And Muscular Dystrophy |
| 06/19/2008 | US20080146584 Method of treating cancers using beta-lapachone or analogs or derivatives thereof |
| 06/19/2008 | US20080146583 Treatment of Incontinence |
| 06/19/2008 | US20080146582 Diazabicyclic Aryl Derivatives and Their Use as Chinolinergic Ligands at the Nicotinic Acetylcholine Receptors |
| 06/19/2008 | US20080146581 Solubility of hydrophobic drugs with a compound having a carboxylic acid moiety |
| 06/19/2008 | US20080146580 Anititumoral Ecteinascidin Derivatives |
| 06/19/2008 | US20080146579 Treatment of patients with chronic pulmonary diseases and nutritional compositions therefore |
| 06/19/2008 | US20080146578 Indolylmaleimide derivatives |
| 06/19/2008 | US20080146577 Methods and Compositions for the Treatment of Attention Deficit Hyperactivity Disorder and Hyperphenylalanemia |
| 06/19/2008 | US20080146576 N-(1-Phthalazin-1-ylpiperidin-4-yl)amides as EP2 receptor modulators |
| 06/19/2008 | US20080146575 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one as crystalline; enzyme poly(ADP-ribose)polymerase (synthase)-1 or poly ADP-ribosyltransferase (PARP-1) inhibitor; anticarcinogenic with BRCA2 deficient phenotype; septic shock, ischemic injury, multiple sclerosis |
| 06/19/2008 | US20080146574 Heterocycle Substituted Carboxylic Acids |
| 06/19/2008 | US20080146573 Preparation and utility of substituted oxzolidinones |
| 06/19/2008 | US20080146572 N-sulfonylurea apoptosis promoters |
| 06/19/2008 | US20080146571 potent deoxycytidine kinase inhibitors; O-linked pyrimidin-4-amine-based compounds |
| 06/19/2008 | US20080146570 Chemical Compounds |
| 06/19/2008 | US20080146569 Nicotinamide Derivatives |
| 06/19/2008 | US20080146568 Spiro-piperidine derivatives |
| 06/19/2008 | US20080146567 5-HT5A receptor antagonists; depression, anxiety disorders, schizophrenia, panic disorders, agoraphobia, social phobia, obsessive compulsive disorders, post-traumatic stress disorders, pain, memory disorders, dementia, disorders of eating behaviors, sexual dysfunction, sleep disorders, drug withdrawal |
| 06/19/2008 | US20080146566 treatment of diseases mediated by cytokines; N-cyclopropyl-4-methyl-3-(1-oxoisoquinolin-2(1H)-yl)benzamide; rheumatoid arthritis, asthma, chronic obstructive pulmonary disease, inflammatory bowel disease, multiple sclerosis, AIDS, septic shock, congestive heart failure, ischaemic heart disease, psoriasis |
| 06/19/2008 | US20080146565 JNK modulators |
| 06/19/2008 | US20080146564 the major cause of lower respiratory tract illness during infancy and childhood |
| 06/19/2008 | US20080146563 1,7-Naphthyridines as Pde4 Inhibitors |
| 06/19/2008 | US20080146562 Halogenated quinazolinyl nitrofurans as antibacterial agents |
| 06/19/2008 | US20080146561 Certain chemical entities, compositions and methods |
| 06/19/2008 | US20080146560 1-[4-(4-amino-5-oxo-5H-pyrido[2,3-d]pyrimidin-8-yl)phenyl]-3-(5-tert-butylisoxazol-3-yl)urea; treatment of tyrosine kinase-induced diseases and conditions, such as angiogenesis, cancer, tumour formation, growth and propagation, arteriosclerosis, ocular diseases, such as age-induced macular degeneration |
| 06/19/2008 | US20080146559 useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors; useful in treating obesity |
| 06/19/2008 | US20080146558 4,5,6,7-Tetrahydro-Thieno [3,2-C] Pyridine Derivatives |
| 06/19/2008 | US20080146557 Vasopressin (V1a) receptor; dysmenorrhea, hypertension, chronic heart failure, liver cirrhosis, nephrotic syndrome, obsessive compulsive disorder, anxiety and depressive disorders; 1'-[(1-benzyl-2-methyl-1H-indol-3-yl)carbonyl]spiro[indene-1,4'-piperidine] one for example |
| 06/19/2008 | US20080146556 Poly (ADP-ribose) polymerase 1 inhibitors as radio-sensitization agents of tumors; 7-methoxy-1,2,3,11-tetrahydro-5,11-diaza-benzo[a]trindene-4,6-dione |
| 06/19/2008 | US20080146555 Uses of Kinase Inhibitors and Compositions Thereof |
| 06/19/2008 | US20080146554 Substituted Cycloalkyl Derivatives, Process for the Manufacture thereof and Use thereof as Medicament |
| 06/19/2008 | US20080146553 Antibiotic compostions and methods for using same |
| 06/19/2008 | US20080146551 Antibacterial Agents |
| 06/19/2008 | US20080146550 HETEROARYLACETAMIDE INHIBITORS OF FACTOR Xa |
| 06/19/2008 | US20080146549 Administering sedative and microdose of opioid antagonist for at least one day followed by detoxifying amount of second antagonist prior to prolonged treatment with third antagonist; low cost; promotes abstinence |
| 06/19/2008 | US20080146548 Ameliorating toxic effects of such as cancer therapy drugs or addictive drug overdose |
| 06/19/2008 | US20080146547 e.g. 4-Chloro-1-hydroxy-phthalazine-6-carboxylic acid [4-chloro-3'-(2-dimethylamino-ethoxy)-biphenyl-3-yl]-amide; multifunctioning protein kinase inhibitors; anticarcinogenic, antiinflammatory, antidiabetic agent, neurodegenerative diseases |
| 06/19/2008 | US20080146546 Bicyclic and Tricyclic Heteroaromatic Compounds |
| 06/19/2008 | US20080146545 Macrocyclic compounds useful as inhibitors of kinases and HSP90 |
| 06/19/2008 | US20080146544 Lisofylline analogs and methods for use |
| 06/19/2008 | US20080146543 Angiotensin II receptor antagonist for the prevention or treatment of systemic diseases in cats |
| 06/19/2008 | US20080146542 Hydrazinocarbonyl-thieno[2,3-C]pyrazoles, Process for Preparing Them, Compositions Containing Them and Use Thereof |
| 06/19/2008 | US20080146541 Methods for treating or preventing sysmptoms of hormonal variations |
| 06/19/2008 | US20080146540 Identifying genetically at risk persons having MAP3K9 associated presence; kits; assay techniques; treating with mixed lineage kinase inhibitors |
| 06/19/2008 | US20080146539 New carboxylic acid amides, the preparation thereof and their use as medicaments |
| 06/19/2008 | US20080146538 exo-3-Bromo-N-((2S)-2-(4-fluorophenyl)-4-(3-(3-hydroxy-8-azabicyclo[3.2.1]oct-8-yl)azetidin-1-yl}butyl)-N-methyl-5-(trifluoromethyl)benzamide;neurokinin NK/tachykinin receptor antagonist; neurodegenerative diseases, antidepressant; gastrointestinal disorder; analgesic, antiinflammatory agent |
| 06/19/2008 | US20080146537 Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors |
| 06/19/2008 | US20080146536 2-Aminoimidazopyridines for treating neurodegenerative diseases |
| 06/19/2008 | US20080146535 i.e. (7R)-7-[(Z)-2-(2-amino-5-chlorothiazol-4-yl)-2-(triphenylmethoxyimino]-acetamido]-3-chloro-8-oxo-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylate triethyl amine salt; bacterial infections caused by methicillin-resistant Staphylococcus aureus and various genus Enterococcus bacteria |
| 06/19/2008 | US20080146534 Pharmaceutical composition for reducing the risks associated with cardiovascular and cerebrovascular diseases |
| 06/19/2008 | US20080146533 Containing tertiary amine linked pyrrolidine, azetidine, morpholine or piperidine group; inhibiting GlyCer synthase, lowering glycosphingolipid levels; collagen vascular diseases, atherosclerosis, diabetic renal hypertrophy |
| 06/19/2008 | US20080146532 Drug Screening and Treatment Methods |
| 06/19/2008 | US20080146531 Therapeutically Active Triazoles and Their Use |
| 06/19/2008 | US20080146530 Re-epithelializing pharmaceutical compositions comprising xanthan gum |
| 06/19/2008 | US20080146529 Skin peeling composition and method |
| 06/19/2008 | US20080146528 stilbene phosphate derivatives; anticarcinogenic agents; bactericide, fungicide; veterinary medicine |
| 06/19/2008 | US20080146527 Antibacterial 1-(4-mono- and di-halomethylsulphonylphenyl)-2-acylamino-3-fluoroproponals and preparation thereof |
| 06/19/2008 | US20080146526 e.g. 3-{[1-Isobutanoyloxyethoxy]carbonylamino}propyl(n-butyl)phosphinic acid; prodrugs of baclofen; gamma aminobutanoic acid antagonist; antidepressant, anxiolytic agent, cognition activator; Alzheimer's disease, epilepsy |
| 06/19/2008 | US20080146525 Composition for promoting cognitive attributes |
| 06/19/2008 | US20080146524 Such as 3-[Hydroxy-(3-phenyl-butyl)-phosphinoyl]-propionyl)-2-amino-(3-methyl-butyrylamino)hexcanoic acid; intermediates; potent and selective endopeptidases inhibitors |